Debiopharm International

www.debiopharm.com

Forum Apres-Demain
Ch de Messidor 5-7
Lausanne
CH-1002
Switzerland

+41 21 321 0111

Activities

Research & Development | Pharmaceutical

Related Companies

Related Content

Novacyt partners with Genepoc to diagnose respiratory infections
Novacyt partners with Genepoc to diagnose respiratory infections
Debiopharm continues fight against antibiotic resistance
Debiopharm continues fight against antibiotic resistance
Debiopharm acquires FibroTrap sample processing technology from Spinomix
Debiopharm acquires FibroTrap sample processing technology from Spinomix
Debiopharm and Nobelex Biotech to develop antibiotics against N. Gonorrhoeae and enteric species
Debiopharm and Nobelex Biotech to develop antibiotics against N. Gonorrhoeae and enteric species
Evotec and Debiopharm to collaborate on development of new cancer treatment
Evotec and Debiopharm to collaborate on development of new cancer treatment
Debiopharm aims to expand activities at its manufacturing facility in Martigny, Switzerland
Debiopharm aims to expand activities at its manufacturing facility in Martigny, Switzerland
Debiopharm Group and TCG Lifesciences to develop new class of antibiotics
Debiopharm Group and TCG Lifesciences to develop new class of antibiotics
Debiopharm to support Ascepion in development of cancer treatment
Debiopharm to support Ascepion in development of cancer treatment
INC Research and Debiopharm agree partnership
INC Research and Debiopharm agree partnership
Debiopharm has a management reshuffle
Debiopharm has a management reshuffle
Debiopharm and Yale University sign worldwide agreement
Debiopharm and Yale University sign worldwide agreement
Novartis wins rights to hepatitis drug
Novartis wins rights to hepatitis drug
Pfizer and Debiopharm to co-develop skin cancer drug
Pfizer and Debiopharm to co-develop skin cancer drug
Debiopharm and Mercury to develop Debio 0930
Debiopharm and Mercury to develop Debio 0930